Subscribe to RSS
DOI: 10.1055/s-2002-33071
© Johann Ambrosius Barth
Relations among serum ferritin, C282Y and H63D mutations in the HFE gene and type 2 diabetes mellitus in the Czech population
Publication History
received 16 October 2001
first decision 26 November 2001
accepted 4 March 2002
Publication Date:
30 July 2002 (online)
![](https://www.thieme-connect.de/media/eced/200205/lookinside/thumbnails/10.1055-s-2002-33071-1.jpg)
Summary
Aims of the study were: (i) to determine the prevalence of mutations C282Y and H63D in the HFE gene causing hereditary hemochromatosis in patients with type 2 diabetes mellitus and non-diabetics, (ii) to investigate the relationship among HFE genotypes, serum ferritin and glucose intolerance and (iii) to assess possible association of HFE mutations with the susceptibility to develop late diabetic complications in the Czech population. Two approaches were employed - the case-control study comprising diabetics and non-diabetic controls (n = 326) and the cross-sectional study comprising subjects with a previously unknown defect of glucose tolerance (n = 113, oral glucose tolerance test performed in each subject). Allele frequencies of C282Y and H63D did not differ between diabetic and control groups nor among subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes. Ferritin levels significantly differed between diabetic and non-diabetic women (P<1.10-3) and among subjects with NGT, IGT and diabetes (P<0.05). Differences in ferritin levels related to particular genotypes of C282Y and H63D were not detected. Prevalence of diabetes in the first and second quartiles of ferritin distribution differed highly significantly from the prevalence in the third and fourth quartiles in women (P = 0.000037), OR = 3.50 (95% CI, 1.89-6.48). The extent of diabetic late complications did not correlate with ferritin plasma levels.
Key words:
Type 2 diabetes mellitus - Ferritin - Hereditary hemochromatosis - HFE - Diabetic complications - Iron
References
- 1 Baynes J W. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 4 405-412
- 2 Baynes J W, Thorpe S R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999; 1 1-9
- 3 Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J. Genetic hemochromatosis, a Celtic disease: is it now time for population screening?. Genet Test. 2001; 5 127-130
- 4 Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino M A, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 1997; 4 828-832
- 5 Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, Cornetti M, Fraquelli M. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med. 1998; 5 370-373
- 6 David V, Jouanolle A M, Fergelot P, Brissot P, Deugnier Y, Le Gall J Y. Molecular genetics of hemochromatosis. Ann Endocrinol (Paris). 1999; 3 204-209
- 7 Dubois-Laforgue D, Caillat-Zucman S, Djilali-Saiah I, Larger E, Mercadier A, Boitard C, Bach J F, Timsit J. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM. Diabetes Care. 1998; 8 1371-1372
- 8 Dubois-Laforgue D, Caillat-Zucman S, Boitard C, Timsit J. Clinical characteristics of type 2 diabetes in patients with mutations of HFE. Diabetes Metab. 2000; 1 65-68
- 9 Ellervik C, Mandrup-Poulsen T, Nordestgaard B G, Larsen L E, Appleyard M, Frandsen M, Petersen P, Schlichting P, Saermark T, Tybjaerg-Hansen A, Birgens H. Prevalence of hereditary aemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet. 2001; 358 1405-1409
- 10 Eshed I, Elis A, Lishner M. Plasma ferritin and type 2 diabetes mellitus: a critical review. Endocr Res. 2001; 27 91-97
- 11 Feder J N, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D A, Basava A, Dormishian F, Domingo R, Ellis M C, Fullan A, Hinton L M, Jones N L, Kimmel B E, Kronmal G S, Lauer P, Lee V K, Loeb D B, Mapa F A, McClelland E, Meyer N C, Mintier G A, Moeller N, Moore T, Morikang E, Prass C E, Quintana L, Starnes S M, Schatzman R C, Brunke K J, Drayna D T, Rischl N J, Bacon B R, Wolff R K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 4 399-408
- 12 Feder J N, Penny D M, Irrinki A, Lee V K, Lebron J A, Watson N, Tsuchihashi Z, Sigal E, Bjorkman P J, Schatzman R C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 1998; 4 1472-1477
- 13 Fernandez-Real J M, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrero D, Fernandez-Castaner M, Soler J. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998; 1 62-68
- 14 Fernandez-Real J M, Vendrell J, Baiget M, Gimferrer E, Ricart W. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care. 1999; 3 525-526
- 15 Ford E S, Cogswell M E. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999; 12 1978-1983
- 16 Frayling T, Ellard S, Grove J, Walker M, Hattersley A T. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet. 1998; 9120 1933-1934
- 17 Gochee P A, Powell L W. What's new in hemochromatosis. Curr Opin Hematol. 2001; 2 98-104
- 18 Griffiths W J, Kelly A L, Smith S J, Cox T M. Localization of iron transport and regulatory proteins in human cells. QJM. 2000; 9 575-587
- 19 Griffiths W J, Sly W S, Cox T M. Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. Gastroenterology. 2001; 6 1420-1429
- 20 Hramiak I M, Finegood D T, Adams P C. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med. 1997; 2 110-118
- 21 Jeffrey G P, Chakrabarti S, Hegele R A, Adams P C. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat. Genet.. 1999; 4 325-326
- 22 Kaňková K, Márová I, Záhejský J, Mužík A, Znojil V, Vácha J. Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism. 2001; 10 1152-1160
- 23 Mowri H O, Frei B, Keaney J F. Glucose enhancement of LDL oxidation is strictly metal ion dependent. Free Radic Biol Med. 2000; 9 814-824
- 24 Nedstrand E, Pertl J, Hammar M. Climacteric symptoms in a postmenopausal Czech population. Maturitas. 1996; 23 85-89
- 25 Orino K, Lehman L, Tsuji Y, Ayaki H, Torti F M. Ferritin and the response to oxidative stress. Biochem J. 2001; 1 241-247
- 26 Parkkila S, Waheed A, Britton R S, Feder J N, Tsuchihashi Z, Schatzman R C, Bacon B R, Sly W S. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA. 1997; 6 2534-2539
- 27 Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet. 1989; 8657 33-234
- 28 Qian M, Liu M, Eaton J W. Transition metals bind to glycated proteins forming redox active “glycochelates”: implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun. 1998; 2 385-389
- 29 Qian M, Eaton J W. Glycochelates and the etiology of diabetic peripheral neuropathy. Free Radic Biol Med. 2000; 4 652-656
- 30 Rahier J, Loozen S, Goebbels R M, Abrahem M. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia. 1987; 1 5-12
- 31 Rochette J, Pointon J J, Fisher C A, Perera G, Arambepola M, Arichchi D S, De Silva S, Vandwalle J L, Monti J P, Old J M, Merryweather-Clarke A T, Weatherall D J, Robson K J. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet. 1999; 4 1056-1062
- 32 Ryab E, O'keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis. 1998; 24 428-432
- 33 Salonen J T, Tuomainen T P, Nyyssonen K, Lakka H M, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ. 1998; 7160 727
- 34 Sampson M J, Williams T, Heyburn P J, Greenwood R H, Temple R C, Wimperis J Z, Jennings B A, Willis G A. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. J Lab Clin Med. 2000; 2 170-173
- 35 Thorbe S R, Baynes J W. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging. 1996; 2 69-77
- 36 Tuomainen T P, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan G A, Salonen J T. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men Diabetes Carey 1997 3: 426-428
- 37 Turnbull A J, Mitchison H C, Peaston R T, Lai L C, Bennett M K, Taylor R, Bassendine M F. The prevalence of hereditary haemochromatosis in a diabetic population. QJM. 1997; 4 271-275
- 38 Waheed A, Parkkila S, Zhou X Y, Tomatsu S, Tsuchihashi Z, Feder J N, Schatzman R C, Britton R S, Bacon B R, Sly W S. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA. 1997; 23 12384-12389
Kateřina KaňkováMD, PhD
Masaryk University
Faculty of Medicine
Department of Pathophysiology
Komenského nám. 2
66243 Brno
Czech Republic
Phone: +420-5-42126556
Fax: +420-5-42126550
Email: kankov@med.muni.cz